CHARLESTON, S.C., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB:RMCP) is entering the final stage of the process to determine its initial global distributors. Since receiving FDA clearance for its RevVac safety syringe, the Company has received numerous inquiries to distribute its product. The potential future distributors have been narrowed down to a pool of just under 50 distributors. Over the next several weeks, the Company will be sending out market samples, confirming interest and commitments, and signing distribution agreements covering certain countries and regions, as well as global licensing agreements.
